Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy

Journal of Nuclear Cardiology

Volumn 19, Issue 1, 2012, Pages 73-83

  Birnie, David ^a   De Kemp, Rob A ^a   Tang, Anthony S ^a   Ruddy, Terence D ^a   Gollob, Michael H ^a   Guo, Ann ^a   Williams, Kathryn ^a   Thomson, Kerry ^a   DaSilva, Jean N ^a   Beanlands, Rob S ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Bundle branch block; Cardiac resynchronization therapy; Imaging; Metabolism; Response

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RUBIDIUM 82; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR SCAR SIZE; MALE; NONISCHEMIC CARDIOMYOPATHY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPTAL GLUCOSE METABOLISM; CARDIOMYOPATHY; HEART VENTRICLE SEPTUM; METABOLISM; PATIENT SELECTION; PROGNOSIS; REPRODUCIBILITY; SCINTISCANNING; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEART SEPTUM; HUMANS; MALE; PATIENT SELECTION; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84861519928     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9483-8     Document Type: Article

References (43)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
3. McAlister FA, Ezekowitz J, Dryden DM, Hooton N, Vandermeer B, Friesen C, et al. Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction. Evid Rep Technol Assess (Full Rep) 2007;152:1-199.
4. Birnie DH, Tang AS. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol 2006;21:20-6. (Pubitemid 43194328)
5. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008;117:2608-16.
6. Diaz-Infante E, Mont L, Leal J, Garcia-Bolao I, Fernandez-Lozano I, Hernandez-Madrid A, et al. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005;95:1436-40. (Pubitemid 40824763)
7. Pitzalis MV, Iacoviello M, Romito R, Massari F, Rizzon B, Luzzi G, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615-22. (Pubitemid 35253639)
8. Yu CM, Fung JW, Zhang Q, Chan CK, Chan YS, Lin H, et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation 2004;110:66-73. (Pubitemid 38880135)
9. Yu CM, Zhang Q, Chan YS, Chan CK, Yip GW, Kum LC, et al. Tissue doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Heart 2006;92:1452-6. (Pubitemid 44578840)
10. Penicka M, Bartunek J, De Bruyne B, Vanderheyden M, Goethals M, De Zutter M, et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue doppler imaging echocardiography. Circulation 2004;109:978-83. (Pubitemid 38282850)
11. Tatsumi K, Tanaka H, Yamawaki K, Ryo K, Omar AM, Fukuda Y, et al. Utility of comprehensive assessment of strain dyssynchrony index by speckle tracking imaging for predicting response to cardiac resynchronization therapy. Am J Cardiol 2011;107:439-46.
12. Auger D, Bertini M, Marsan NA, Hoke U, Ewe SH, Thijssen J, et al. Prediction of response to cardiac resynchronization therapy combining two different three-dimensional analyses of left ventricular dyssynchrony. Am J Cardiol 2011;108:711-7.
13. Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76. (Pubitemid 43879472)
14. White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006;48:1953-60. (Pubitemid 44738444)
15. Ypenburg C, Roes SD, Bleeker GB, Kaandorp TA, de Roos A, Schalij MJ, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol 2007;99:657-60.
16. Birnie DH, de Kemp R, Ruddy TD, Tang AS, Williams K, Guo A, et al. Effect of lateral wall scar on reverse remodeling with cardiac resynchronization therapy. Heart Rhythm 2009;6:1721-6.
17. Prinzen FW, Augustijn CH, Arts T, Allessie MA, Reneman RS. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol 1990;259:H300-8. (Pubitemid 20259403)
18. Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work during ventricular pacing: Experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 1999;33:1735-42.
19. Wyman BT, Hunter WC, Prinzen FW, McVeigh ER. Mapping propagation of mechanical activation in the paced heart with MRI tagging. Am J Physiol 1999;276:H881-91. (Pubitemid 29157460)
20. Inoue N, Takahashi N, Ishikawa T, Sumita S, Kobayashi T, Matsushita K, et al. Reverse perfusion-metabolism mismatch predicts good prognosis in patients undergoing cardiac resynchronization therapy: A pilot study. Circ J 2007;71:126-31. (Pubitemid 46045562)
21. Thompson K, Saab G, Birnie D, Chow BJ, Ukkonen H, Ananthasubramaniam K, et al. Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy? J Nucl Med 2006;47:1763-8. (Pubitemid 47544998)
22. Neri G, Zanco P, Bertaglia E, Zerbo F, Zanon F, Buchberger R. Myocardial perfusion and metabolic changes induced by conventional right and biventricular pacing in dilated cardiomyopathy evaluated by positron emission tomography. Ital Heart J 2002;3:637-42. (Pubitemid 36131833)
23. Nowak B, Sinha AM, Schaefer WM, Koch KC, Kaiser HJ, Hanrath P, et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2003;41:1523-8. (Pubitemid 36543371)
24. Neri G, Zanco P, Zanon F, Buchberger R. Effect of biventricular pacing on metabolism and perfusion in patients affected by dilated cardiomyopathy and left bundle branch block: Evaluation by positron emission tomography. Europace 2003;5:111-5. (Pubitemid 36149980)
25. Beanlands RS, Ruddy TD, de Kemp RA, Iwanochko RM, Coates G, Freeman M, et al. Positron emission tomography and recovery following revascularization (PARR-1): The importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 2002;40:1735-43. (Pubitemid 35341950)
26. Beanlands RS, Nichol G, Huszti E, Humen D, RacineN, FreemanM, et al. F-18-fluorodeoxyglucose positron emission tomography imaging- assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007;50:2002-12. (Pubitemid 350054917)
27. Massardo T, Gal RA, Grenier RP, Schmidt DH, Port SC. Left ventricular volume calculation using a count-based ratio method applied to multigated radionuclide angiography. J Nucl Med 1990;31:450-6. (Pubitemid 20144712)
28. Lalonde M, Birnie D, Ruddy TD, de Kemp RA, Wassenaar RW. SPECT blood pool phase analysis can accurately and reproducibly quantify mechanical dyssynchrony. J Nucl Cardiol 2010;17:803-10.
29. Bashore TM, Stine RA, Shaffer PB, Bush CA, Leier CV, Schaal SF. The noninvasive localization of ventricular pacing sites by radionuclide phase imaging. Circulation 1984;70:681-94. (Pubitemid 14020667)
30. Botvinick EH, Frais MA, Shosa DW, O'Connell JW, Pacheco- Alvarez JA, Scheinman M, et al. An accurate means of detecting and characterizing abnormal patterns of ventricular activation by phase image analysis. Am J Cardiol 1982;50:289-98. (Pubitemid 12059023)
31. Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006;13:e121-51. (Pubitemid 44913647)
32. Klein R, Lortie M, Adler A, Beanlands R, deKemp R. Fully automated software for polar-map registration and sampling from PET images. IEEE Nucl Sci Symp Conf Rec 2006;6:3185-8.
33. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ, et al. PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol 2009;16:651.
34. Vitale GD, de Kemp RA, Ruddy TD, Williams K, Beanlands RS. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med 2001;42:1730-6. (Pubitemid 34016339)
35. Kerlan JE, Sawhney NS, Waggoner AD, Chawla MK, Garhwal S, Osborn JL, et al. Prospective comparison of echocardiographic atrioventricular delay optimization methods for cardiac resynchronization therapy. Heart Rhythm 2006;3:148-54. (Pubitemid 43149986)
36. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42. (Pubitemid 34262671)
37. Altehoefer C, vom DJ, Buell U. Septal glucose metabolism in patients with coronary artery disease and left bundle-branch block. Coron Artery Dis 1993;4:569-72. (Pubitemid 23274205)
38. Zanco P, Desideri A, Mobilia G, Cargnel S, Milan E, Celegon L, et al. Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses. J Nucl Med 2000;41:973-7. (Pubitemid 30396643)
39. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 1998;4:1269-75. (Pubitemid 28512107)
40. Bleeker GB, Mollema SA, Holman ER, Van d Veire N, Ypenburg C, Boersma E, et al. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: Analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation 2007;116:1440-8. (Pubitemid 47480634)
41. Chen J, Bax JJ, Henneman MM, Boogers MJ, Garcia EV. Is nuclear imaging a viable alternative technique to assess dyssynchrony? Europace 2008;10:iii101-5.
42. Henneman MM, Chen J, Ypenburg C, Dibbets P, Bleeker GB, Boersma E, et al. Phase analysis of gated myocardial perfusion single-photon emission computed tomography compared with tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol 2007;49:1708-14. (Pubitemid 46589921)
43. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: Quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 2006;113:266-72.